Previous 10 |
home / stock / igx:cc / igx:cc news
SAINT LAURENT, Quebec, July 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “ Company ” or “ IntelGenx ”) announces that, as previously disclosed on June 1, 2022 and in accordance with the terms of the trust inde...
IIROC Trading Halt - IGX.DB Canada NewsWire TORONTO , June 30, 2022 /CNW/ - The following issues have been halted by IIROC: Company: IntelGenx Technologies Corp. TSX Symbol: IGX.DB All Issues: No Reason: Pending Delisting Halt Time (ET): ...
News, Short Squeeze, Breakout and More Instantly...
Intelgenx Technologies Corp. Company Name:
IGX:CC Stock Symbol:
TSXC Market:
Intelgenx Technologies Corp. Website:
MONTREAL, July 19, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”) (OTC: IGXT) , a leading drug delivery company focused on the development and manufacturing of pharmaceutical films, announced today that the Pha...
MONTREAL, July 03, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “Company” or “IntelGenx” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), has successfully completed the BUENA Alzheimer’s disease (AD) study. The BUENA study was designed as ...
MONTREAL, June 11, 2024 (GLOBE NEWSWIRE) -- IntelGenx Corp. (the “ Company ” or “ IntelGenx ” a subsidiary of IntelGenx Technologies Corp.) (OTCQB: IGXT; TSX: IGX), was granted protection pursuant to an order (as amended or amended and restated from time t...